Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Somm, E.
Right arrow Articles by Meier, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Somm, E.
Right arrow Articles by Meier, C. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:3503-3509, 2005
© 2005 by the American Diabetes Association, Inc.

Decreased Fat Mass in Interleukin-1 Receptor Antagonist–Deficient Mice

Impact on Adipogenesis, Food Intake, and Energy Expenditure

Emmanuel Somm1, Elvire Henrichot1, Agnès Pernin1, Cristiana E. Juge-Aubry1, Patrick Muzzin2, Jean-Michel Dayer3, Martin J.H. Nicklin4, and Christoph A. Meier1

1 Endocrine Unit, Department of Internal Medicine, University Hospital, and Department of Cellular Physiology and Metabolism, University Medical Center, Geneva, Switzerland
2 Department of Cellular Physiology and Metabolism, University Medical Center, Geneva, Switzerland
3 Division of Immunology and Allergology, Department of Internal Medicine, University Hospital, Geneva, Switzerland
4 Division of Genomic Medicine, University of Sheffield, Royal Hallamshire Hospital, Sheffield, U.K

Interleukin (IL)-1 is a regulator of inflammation but is also implicated in the control of energy homeostasis. Because the soluble IL-1 receptor antagonist (IL-1Ra) is markedly increased in the serum of obese patients and is overexpressed in white adipose tissue in obesity, we studied the metabolic consequences of genetic IL-1Ra ablation in mice. We have shown that IL-1Ra–/– mice have a lean phenotype due to decreased fat mass, related to a defect in adipogenesis and increased energy expenditure. The adipocytes were smaller in these animals, and the expression of genes involved in adipogenesis was reduced. Energy expenditure as measured by indirect calorimetry was elevated, and weight loss in response to a 24-h fast was increased in IL-1Ra–/– animals compared with wild-type mice. Lipid oxidation of IL-1Ra–/– mice was higher during the light period, reflecting their reduction in diurnal food intake. Interestingly, IL-1Ra–/– and IL-1Ra+/– mice presented an attenuation in high-fat diet–induced caloric hyperphagia, indicating a better adaptation to hypercaloric alimentation, which is in line with the role of IL-1Ra as a mediator of leptin resistance. Taken together, we show that IL-1Ra is an important regulator of adipogenesis, food intake, and energy expenditure.


Address correspondence and reprint requests to Dr. Christoph A. Meier, Endocrine Unit, University Hospital Geneva, 24, rue Micheli-du-Crest, CH-1211 Geneva 14, Switzerland. E-mail: christoph.meier{at}medecine.unige.ch

Key Words: C/EBP, CAAT enhancer–binding protein • eWAT, epididymal white adipose tissue • IL, interleukin • IL-1Ra, IL-1 receptor antagonist • LPL, lipoprotein lipase • PPAR, peroxisome proliferator–activated receptor • RER, respiratory exchange ratio • TNF, tumor necrosis factor • UCP, uncoupling protein • WAT, white adipose tissue


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
E. P. Zorrilla, M. Sanchez-Alavez, S. Sugama, M. Brennan, R. Fernandez, T. Bartfai, and B. Conti
Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency
PNAS, June 26, 2007; 104(26): 11097 - 11102.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. E. Trujillo and P. E. Scherer
Adipose Tissue-Derived Factors: Impact on Health and Disease
Endocr. Rev., December 1, 2006; 27(7): 762 - 778.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. C. Molero, N. Turner, C. B.F. Thien, W. Y. Langdon, D. E. James, and G. J. Cooney
Genetic Ablation of the c-Cbl Ubiquitin Ligase Domain Results in Increased Energy Expenditure and Improved Insulin Action
Diabetes, December 1, 2006; 55(12): 3411 - 3417.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.